Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Complete Remission”

294 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 294 results

Testing effectiveness (Phase 2)Looking for participantsNCT06764355
What this trial is testing

Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCCTotal Neoadjuvant TreatmentPathological Complete Response
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Testing effectiveness (Phase 2)UnknownNCT02059876
What this trial is testing

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 60
Testing effectiveness (Phase 2)UnknownNCT03444025
What this trial is testing

Neoadjuvant Goserelin for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer Triple Negative
Kasr El Aini Hospital 180
Not applicableStudy completedNCT02896829
What this trial is testing

Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
University Hospital, Bordeaux 97
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Not applicableStudy completedNCT04298619
What this trial is testing

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Who this might be right for
Hodgkin LymphomaHigh RiskRelapse
Federico II University 123
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04229979
What this trial is testing

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Who this might be right for
Acute Myeloid Leukemia
Sellas Life Sciences Group 127
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Not applicableUnknownNCT03474341
What this trial is testing

Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+1 more
UMC Utrecht 200
Not applicableUnknownNCT06061263
What this trial is testing

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy

Who this might be right for
Esophageal Cancer
Sun Yat-sen University 96
Not applicableUnknownNCT04815694
What this trial is testing

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy

Who this might be right for
Neoadjuvant ChemoradiotherapyLocally Advanced Rectal CancerPathological Complete Response
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 63
Testing effectiveness (Phase 2)Looking for participantsNCT06608732
What this trial is testing

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT06182657
What this trial is testing

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Who this might be right for
Nasopharyngeal CarcinomaPathologic Complete ResponseTumor Microenvironment
Jiangxi Provincial Cancer Hospital 300
Not applicableStudy completedNCT02232711
What this trial is testing

Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting

Who this might be right for
Upper Respiratory Infections
BioFire Diagnostics, LLC 1,082
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Not applicableStudy completedNCT04939103
What this trial is testing

TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer

Who this might be right for
EUS-FNARectal CancerPathological Complete Remission
Sixth Affiliated Hospital, Sun Yat-sen University 63
Load More Results